← Back to home
Comparison · Analytics

clinify vs monitOS

A side-by-side editorial comparison of clinify and monitOS — release velocity, themes, recent moves, and the top alternatives to consider.

clinify vs monitOS: at a glance

FeatureclinifymonitOS
SectorAnalyticsAnalytics
Velocity score2.50.0
Sparks · 30d00
Top themesclinical-trials, r-package, document-generation, table-formattingclinical trials, overall survival, novartis, shiny
Last editorial update1h ago45m ago
WebsiteVisit →Visit →

What is clinify?

Clinical-table typesetting for R, closing the gap between R output and regulatory Word documents

clinify renders clinical trial tables into Word documents through {officer}, aiming at the layout conventions regulatory submissions expect. 0.4.0 is the current CRAN release and folds in an unreleased 0.3.1. The recent work is almost entirely about header and spacing control: which adjacent header cells merge, where the rule under a spanner starts and stops, and how much vertical space sits above, below and between header rows and the table body.

Read the full clinify trajectory →

What is monitOS?

monitOS relicenses to MIT, the clearest signal in a sparse Novartis release feed.

monitOS is Novartis's R package for monitoring overall survival in clinical trials, with an accompanying Shiny app. The 0.1.6 release changes the licence to MIT, fixes a shiny import problem and an infinite-value bug in the app, and adds spell checking plus issue-tracker and website links. The prior release carries no notes at all beyond a link to the commit history.

Read the full monitOS trajectory →

clinify vs monitOS: editorial side-by-side

C
clinify
ANALYTICS
2.5

Clinical-table typesetting for R, closing the gap between R output and regulatory Word documents

◆ Current state

clinify renders clinical trial tables into Word documents through {officer}, aiming at the layout conventions regulatory submissions expect. 0.4.0 is the current CRAN release and folds in an unreleased 0.3.1. The recent work is almost entirely about header and spacing control: which adjacent header cells merge, where the rule under a spanner starts and stops, and how much vertical space sits above, below and between header rows and the table body.

◆ Where it's heading

The package is moving from producing a correct table toward producing one that survives an organisation's house style. 0.4.0's additions are all written to hold under a customised `clinify_table_default()` — `clin_spanner_rule()` draws after the default styling function so it persists when a house style clears the borders it started from, and takes an `officer::fp_border()` or `FALSE` so a style can decline the rule entirely. The earlier 0.3.0 line did the structural work, introducing `clindoc()` document objects that accept multiple tables plus automatic pagination.

◆ Prediction

Expect continued refinement of layout primitives that follow the table rather than fixed column numbers, since both new 0.4.0 functions were built specifically to track spanners and headers as a layout changes. The entries do not indicate a move beyond Word output.

M
monitOS
ANALYTICS
0.0

monitOS relicenses to MIT, the clearest signal in a sparse Novartis release feed.

◆ Current state

monitOS is Novartis's R package for monitoring overall survival in clinical trials, with an accompanying Shiny app. The 0.1.6 release changes the licence to MIT, fixes a shiny import problem and an infinite-value bug in the app, and adds spell checking plus issue-tracker and website links. The prior release carries no notes at all beyond a link to the commit history.

◆ Where it's heading

For a package published by a pharmaceutical sponsor, the licence change is the substantive item — MIT removes friction for reuse outside Novartis, and the added issue link and website point the same way, toward outside users. Everything else is packaging hygiene. At 0.1.6 with two releases nine months apart, the statistical methodology looks settled while the distribution around it is being tidied.

◆ Prediction

The open-sourcing signals suggest the next release will respond to outside issue reports; the entries give no indication of methodology changes.

Alternatives to clinify and monitOS

Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either clinify or monitOS.

See all clinify alternatives → · See all monitOS alternatives →

Recent activity from clinify and monitOS

Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.

  1. 13d agoclinifyFiner header merging, spanner rules and header padding
  2. 1y agomonitOSRelicensed to MIT; Shiny import and inf-value fixes
  3. 1y agoclinifyclindoc document objects and automatic pagination
  4. 1y agomonitOSv0.1.5-release

Frequently asked questions

What is the difference between clinify and monitOS?

They serve adjacent needs but don't currently overlap on shipped themes. clinify is currently shipping more aggressively (velocity 2.5 vs 0.0), with 0 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.

Is clinify better than monitOS?

Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. clinify is currently shipping more aggressively (velocity 2.5 vs 0.0), with 0 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.

What are the best alternatives to clinify?

Top clinify alternatives in Analytics are ranked by recent ship velocity. Browse the "clinify alternatives" section above for the current picks, or visit /alternatives/clinify-r for the full list with editorial commentary on each.

What are the best alternatives to monitOS?

Top monitOS alternatives in Analytics are ranked by recent ship velocity. Browse the "monitOS alternatives" section above for the current picks, or visit /alternatives/monitos for the full list with editorial commentary on each.